Anfield Capital Management, LLC Ark Genomic Revolution ETF (De Transaction History
Anfield Capital Management, LLC
- $255 Million
- Q3 2024
A detailed history of Anfield Capital Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Anfield Capital Management, LLC holds 301 shares of ARKG stock, worth $7,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
301
Previous 301
-0.0%
Holding current value
$7,127
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$70 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$68.7 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$57.5 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$42.9 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$39.8 Million0.03% of portfolio